https://www.selleckchem.com/pr....oducts/lusutrombopag
Optimal time between neoadjuvant radio-chemotherapy period and surgery remains controversial in patients with rectal cancer an increasing number of studies show results in favour of a long interval. We conducted a retrospective analysis of the cases of low-middle rectal adenocarcinoma undergoing neoadjuvant RT-CT and surgery the primary endpoint was the complete pathological response rate and the secondary endpoint the rate of complications. We analysed cases from 1/01/2003 to 31/12/2018 divided in two periods from 2003 to 2010 (2